After Adcomm’s Vaccine Recommendation, Can Novavax Make a Covid Comeback?

Thursday, the FDA’s Vaccines and Related Biological Products Advisory Committee unanimously recommended that for the upcoming vaccination campaign, current COVID-19 shots should be updated to cover the latest XBB Omicron subvariant.